Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma

Keyphrases

• Multiple Myeloma 100%
• Newly Diagnosed multiple Myeloma 100%
• Integrative Network Analysis 100%
• CoMMpass 66%
• Myeloma 66%
• Genetic Modification 33%
• Clinical Practice 33%
• Therapeutic Target 33%
• Disease Biology 33%
• Malignancy 33%
• Genetic Events 33%
• Clinically Significant 33%
• Clinical Data 33%
• Network Model 33%
• Network Biology 33%
• Molecular Data 33%
• Therapeutic Potential 33%
• Integrative Network 33%
• Network Features 33%
• Sequence Method 33%
• Disease Stage 33%
• Molecular Targets 33%
• Novel Regulator 33%
• Clinical Characteristics 33%
• Disease Pattern 33%
• Novel Genes 33%
• Molecular Heterogeneity 33%
• New Patients 33%
• Structural Rearrangement 33%
• Molecular Features 33%
• High-risk Myeloma 33%
• Deep Sequencing 33%
• Cdc42 33%
• Clinical Heterogeneity 33%
• Co-expressed Genes 33%
• Trait Marker 33%
• Genomic Markers 33%
• Clonality 33%
• Clinical Genomics 33%
• Early Progression 33%
• Bone Marrow Plasma Cells 33%
• MMSET 33%
• CLEC11A 33%
• Genomic Groups 33%
• Molecular Disease 33%
• Gene Prognostic Signature 33%

Biochemistry, Genetics and Molecular Biology

• Genomics 100%
• Genetics 50%
• Cancer Staging 50%
• Deep Sequencing 50%
• Clonal Variation 50%
• Clonality 50%
• Molecular Disease 50%
• Immunoglobulin Producing Cell 50%